Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice

Plant Cell Reports

Volumn 34, Issue 6, 2015, Pages 969-980

  Nahampun, Hartinio N ^a   Bosworth, Brad ^a   Cunnick, Joan ^a   Mogler, Mark ^b   Wang, Kan ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b Harrisvaccines Inc   (United States)

Author keywords

Antigens; H3N2; Nucleoprotein; Plant based vaccine; Transgenic maize

Indexed keywords

CORE PROTEIN; INFLUENZA VACCINE; NP PROTEIN, INFLUENZA A VIRUS; RECOMBINANT PROTEIN; RNA BINDING PROTEIN;

ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS (H3N2); MAIZE; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOGENICITY; PIG; PLANT SEED; TRANSGENIC PLANT;

ADMINISTRATION, ORAL; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; MICE, INBRED BALB C; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS; RNA-BINDING PROTEINS; SEEDS; SUS SCROFA; VIRAL CORE PROTEINS; ZEA MAYS;

EID: 84939933128     PISSN: 07217714     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00299-015-1758-0     Document Type: Article

References (76)

1. Ashraf S, Kong W, Wang S, Yang J, Curtiss R 3rd (2011) Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine. Vaccine 29(23):3990–4002
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
3. Brett IC, Johansson BE (2005) Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Virology 339(2):273–280
4. Carragher DM, Kaminski DA, Moquin A, Hartson L, Randall TD (2008) A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. Journal of immunology 181(6):4168–4176
5. Chen Z, Kadowaki S, Hagiwara Y, Yoshikawa T, Matsuo K, Kurata T, Tamura S (2000) Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine 18(28):3214–3222
6. Chen Q, Kuang H, Wang H, Fang F, Yang Z, Zhang Z, Zhang X, Chen Z (2009) Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus. Virus Genes 38(1):30–38
7. Chikwamba R, Cunnick J, Hathaway D, McMurray J, Mason H, Wang K (2002) A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Res 11(5):479–493
8. Ciacci-Zanella JR, Vincent AL, Prickett JR, Zimmerman SM, Zimmerman JJ (2010) Detection of anti-influenza A nucleoprotein antibodies in pigs using a commercial influenza epitope-blocking enzyme-linked immunosorbent assay developed for avian species. J Vet Diagn Invest 22(1):3–9
9. Cohen AD, Boyer JD, Weiner DB (1998) Modulating the immune response to genetic immunization. FASEB J 12(15):1611–1626
10. Crawford J, Wilkinson B, Vosnesensky A, Smith G, Garcia M, Stone H, Perdue ML (1999) Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine 17(18):2265–2274
11. Daniell H, Streatfield SJ, Wycoff K (2001) Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci 6(5):219–226
12. Daniell H, Singh ND, Mason H, Streatfield SJ (2009) Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci 14(12):669–679
13. Doyle JJ, Doyle JL (1990) Isolation of plant DNA from fresh tissue. Focus 12:13–15
14. Du L, Zhou Y, Jiang S (2010) Research and development of universal influenza vaccines. Microbes Infect 12(4):280–286
15. Eliasson DG, El Bakkouri K, Schon K, Ramne A, Festjens E, Lowenadler B, Fiers W, Saelens X, Lycke N (2008) CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine. Vaccine 26(9):1243–1252
16. Ellgaard L, Helenius A (2003) Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 4(3):181–191
17. Epstein SL, Tumpey TM, Misplon JA, Lo CY, Cooper LA, Subbarao K, Renshaw M, Sambhara S, Katz JM (2002) DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. Emerg Infect Dis 8(8):796–801
18. Epstein SL, Kong W-P, Misplon JA, Lo C-Y, Tumpey TM, Xu L, Nabel GJ (2005) Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. Vaccine 23(46–47):5404–5410
19. Flavell RB (1994) Inactivation of gene expression in plants as a consequence of specific sequence duplication. Proc Natl Acad Sci USA 91(9):3490–3496
20. Frame BR, Shou H, Chikwamba RK, Zhang Z, Xiang C, Fonger TM, Pegg SEK, Li B, Nettleton DS, Pei D, Wang K (2002) Agrobacterium tumefaciens-mediated transformation of maize embryos using a standard binary vector system. Plant Physiol 129(1):13–22
21. Garten RJ, Davis CT, Russell CA et al (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325(5937):197–201
22. Geisbert TW (2014) Medical research: ebola therapy protects severely ill monkeys. Nature 514(7520):41–43
23. Giddings G, Allison G, Brooks D, Carter A (2000) Transgenic plants as factories for biopharmaceuticals. Nat Biotech 18(11):1151–1155
24. Gupta R, Jung E, Brunak S (2004) Prediction of N-glycosylation sites in human proteins (in preparation)
25. Hayden CA, Egelkrout EM, Moscoso AM, Enrique C, Keener TK, Jimenez-Flores R, Wong JC, Howard JA (2012) Production of highly concentrated, heat-stable hepatitis B surface antigen in maize. Plant Biotechnol J 10(8):979–984
26. Hood EE, Helmer GL, Fraley RT, Chilton MD (1986) The hypervirulence of Agrobacterium tumefaciens A281 is encoded in a region of pTiBo542 outside of T-DNA. J Bacteriol 168(3):1291–1301
27. Hood EE, Bailey MR, Beifuss K, Magallanes-Lundback M, Horn ME, Callaway E, Drees C, Delaney DE, Clough R, Howard JA (2003) Criteria for high-level expression of a fungal laccase gene in transgenic maize. Plant Biotechnol J 1(2):129–140
28. Huang B, Wang W, Li R, Wang X, Jiang T, Qi X, Gao Y, Tan W, Ruan L (2012) Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice. Virol J 9(1):322
29. Hutchinson EC, von Kirchbach JC, Gog JR, Digard P (2010) Genome packaging in influenza A virus. J Gen Virol 91(2):313–328
30. Jimenez GS, Planchon R, Wei Q, Rusalov D, Geall A, Enas J, Lalor P, Leamy V, Vahle R, Luke CJ, Rolland A, Kaslow DC, Smith LR (2007) Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge. Hum Vaccines 3(5):157–164
31. Kim S-H, Kim JY, Choi Y, Nguyen HH, Song MK, Chang J (2013) Mucosal vaccination with recombinant adenovirus encoding nucleoprotein provides potent protection against influenza virus infection. PLoS ONE 8(9):e75460
32. Kodihalli S, Goto H, Kobasa DL, Krauss S, Kawaoka Y, Webster RG (1999) DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J Virol 73(3):2094–2098
33. Kreijtz JHCM, de Mutsert G, van Baalen CA, Fouchier RAM, Osterhaus ADME, Rimmelzwaan GF (2008) Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 82(11):5161–5166
34. Kuiken T, Holmes EC, McCauley J, Rimmelzwaan GF, Williams CS, Grenfell BT (2006) Host species barriers to influenza virus infections. Science 312(5772):394–397
35. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
36. Lambert LC, Fauci AS (2010) Influenza vaccines for the future. N Engl J Med 363(21):2036–2044
37. LaMere MW, Lam HT, Moquin A, Haynes L, Lund FE, Randall TD, Kaminski DA (2011a) Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus. J Immunol 186(7):4331–4339
38. LaMere MW, Moquin A, Lee FE, Misra RS, Blair PJ, Haynes L, Randall TD, Lund FE, Kaminski DA (2011b) Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance. J Virol 85(10):5027–5035
39. Lee G, Na YJ, Yang B-G et al (2014) Oral immunization of haemaggulutinin H5 expressed in plant endoplasmic reticulum with adjuvant saponin protects mice against highly pathogenic avian influenza A virus infection. Plant Biotechnol J 13(1):62–72
40. Luo J, Zheng D, Zhang W et al (2012) Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein. Virol J 9(1):286
41. Ma JKC, Drake PMW, Christou P (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4(10):794–805
42. Markine-Goriaynoff D, van der Logt JT, Truyens C et al (2000) IFN-gamma-independent IgG2a production in mice infected with viruses and parasites. Int Immunol 12(2):223–230
43. Marks MD, Lindell JS, Larkins BA (1985) Quantitative analysis of the accumulation of Zein mRNA during maize endosperm development. J Biol Chem 260(30):16445–16450
44. Mason HS, DeWald DB, Mullet JE (1993) Identification of a methyl jasmonate-responsive domain in the soybean vspB promoter. Plant Cell 5(3):241–251
45. Medina RA, García-Sastre A (2011) Influenza A viruses: new research developments. Nat Rev Micro 9(8):590–603
46. Moeller L, Gan Q, Wang K (2009) A bacterial signal peptide is functional in plants and directs proteins to the secretory pathway. J Exp Bot 60(12):3337–3352
47. Moravec T, Schmidt MA, Herman EM, Woodford-Thomas T (2007) Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine. Vaccine 25(9):1647–1657
48. Munro S, Pelham HRB (1987) A C-terminal signal prevents secretion of luminal ER proteins. Cell 48(5):899–907
49. Orellana-Escobedo L, Korban SS, Rosales-Mendoza S (2014) Seed-Based Expression Strategies. In: Rosales-Mendoza S (ed) Genetically engineered plants as a source of vaccines against wide spread diseases. Springer, New York, pp 79–93
50. Ou J, Guo Z, Shi J, Wang X, Liu J, Shi B, Guo F, Zhang C, Yang D (2014) Transgenic rice endosperm as a bioreactor for molecular pharming. Plant Cell Rep 33(4):585–594
51. Paz M, Shou H, Guo Z, Zhang Z, Banerjee A, Wang K (2004) Assessment of conditions affecting Agrobacterium -mediated soybean transformation using the cotyledonary node explant. Euphytica 136(2):167–179
52. Perea Arango I, Loza Rubio E, Rojas Anaya E et al (2008) Expression of the rabies virus nucleoprotein in plants at high-levels and evaluation of immune responses in mice. Plant Cell Rep 27(4):677–685
53. Pertmer TM, Roberts TR, Haynes JR (1996) Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J Virol 70(9):6119–6125
54. Portela AN, Digard P (2002) The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J Gen Virol 83(4):723–734
55. Qiu X, Wong G, Audet J et al (2014) Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514(7520):47–53
56. Rosales-Mendoza S, Salazar-Gonzalez JA (2014) Immunological aspects of using plant cells as delivery vehicles for oral vaccines. Expert Rev Vaccines 13(6):737–749
57. Rose MA, Zielen S, Baumann U (2012) Mucosal immunity and nasal influenza vaccination. Expert Rev Vaccines 11(5):595–607
58. Russell D, Fromm M (1997) Tissue-specific expression in transgenic maize of four endosperm promoters from maize and rice. Transgenic Res 6(2):157–168
59. Rybicki EP (2010) Plant-made vaccines for humans and animals. Plant Biotechnol J 8(5):620–637
60. Sanchez MV, Ebensen T, Schulze K et al (2014) Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge. PLoS ONE 9(8):e104824
61. Schubert D, Lechtenberg B, Forsbach A, Gils M, Bahadur S, Schmidt R (2004) Silencing in arabidopsis T-DNA transformants: the predominant role of a gene-specific RNA sensing mechanism versus position effects. Plant Cell 16(10):2561–2572
62. Stam M, Mol JNM, Kooter JM (1997) Review article: the silence of genes in transgenic plants. Ann Bot 79(1):3–12
63. Steel J, Lowen AC, Wang TT, Yondola M, Gao Q, Haye K, García-Sastre A, Palese P (2010) Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 1(1):e00018–10
64. Stoger E, Fischer R, Moloney M, Ma JK-C (2014) Plant molecular pharming for the treatment of chronic and infectious diseases. Annu Rev Plant Biol 65(1):743–768
65. Townsend ARM, McMichael AJ, Carter NP, Huddleston JA, Brownlee GG (1984) Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell 39(1):13–25
66. Townsend ARM, Gotch FM, Davey J (1985) Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 42(2):457–467
67. Turrell L, Lyall JW, Tiley LS, Fodor E, Vreede FT (2013) The role and assembly mechanism of nucleoprotein in influenza A virus ribonucleoprotein complexes. Nat Commun 4:1591
68. Twyman R, Schillberg S, Fischer R (2012) The production of vaccines and therapeutic antibodies in plants. In: Wang A, Ma S (eds) Molecular farming in plants: recent advances and future prospects. Springer, Netherlands, pp 145–159
69. Vander Veen RL, Mogler MA, Russell BJ, Loynachan AT, Harris DL, Kamrud KI (2013) Haemagglutinin and nucleoprotein replicon particle vaccination of swine protects against the pandemic H1N1 2009 virus. Vet Rec 173(14):344
70. Wang W, Huang B, Jiang T, Wang X, Qi X, Tan W, Ruan L (2014) Maximal immune response and cross protection by influenza virus nucleoprotein derived from E. coli using an optimized formulation. Virology 468–470C:265–273
71. Wraith DC, Vessey AE, Askonas BA (1987) Purified influenza virus nucleoprotein protects mice from lethal infection. J Gen Virol 68(2):433–440
72. Wu J, Yu L, Li L, Hu J, Zhou J, Zhou X (2007) Oral immunization with transgenic rice seeds expressing VP2 protein of infectious bursal disease virus induces protective immune responses in chickens. Plant Biotechnol J 5(5):570–578
73. Yewdell JW, Bennink JR, Smith GL, Moss B (1985) Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci 82(6):1785–1789
74. Zhai Z, Liu Y, Wu L, Senchina DS, Wurtele ES, Murphy PA, Kohut ML, Cunnick JE (2007) Enhancement of innate and adaptive immune functions by multiple Echinacea species. J Med Food 10(3):423–434
75. Zheng M, Luo J, Chen Z (2014) Development of universal influenza vaccines based on influenza virus M and NP genes. Infection 42(2):251–262
76. Zhou D, Wu TL, Lasaro MO et al (2010) A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challenge. Mol Ther 18(12):2182–2189